Stability of Four Commercial Products Delivered by Mail Order

Hadzija, Boka W; Shrewsbury, Robert P

Abstract

Stability of Four Commercial Products Delivered by Mail Order

Author(s): Hadzija Boka W, Shrewsbury Robert P

Issue: Jan/Feb 1999 - Dental Compounding

View All Articles in Issue

Page(s): 59-63

Download in electronic PDF format for $75

Abstract

The purpose of this study was to investigate the stability of four commercial tablets commonly shipped via mail-order delivery. The products were: enalapril maleate l0-mg tablets, digoxin 0.25-mg tablets, clorazepate dipotassium 7.5-mg tablets and pyridostigmine bromide 60-mg tablets. The stability studies were conducted at 50°C, and tablets were exposed for three, seven and 14 days to that temperature. The results demonstrated that all tablets studied were stable in these conditions for their exposure time. Therefore, it appears that all the tablets remained stable and could be used with confidence in mail-order delivery provided the original product packaging is not compromised.

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
Jan/Feb 1999 Pg. 59-63	Stability of Four Commercial Products Delivered by Mail Order Author(s): Hadzija Boka W, Shrewsbury Robert P
Nov/Dec 2023 Pg. 474-481	Nonsterile Basics of Compounding: Using U.S. Food and Drug Administration-approved Commercial Products as Ingredients Author(s): Allen Loyd V Jr
Jul/Aug 2004 Pg. 292-293	Standard Operating Procedure: Determining and Documenting the Commercial Unavailability of a Manufactured Drug Product Author(s): Allen Loyd V Jr
May/Jun 2021 Pg. 211-216	Quality Control: Testing for "Micromonsters": Viable Air and Surface Sampling in Aseptic Compounding Author(s): Mulder Kyle
Nov/Dec 2005 Pg. 462-469	Quality Control Analytical Methods: Quality Issues Related to Compounding with Commercial Products Author(s): Allen Loyd V Jr
Jul/Aug 2003 Pg. 292-293	How to Handle a Product Recall Author(s): Allen Loyd V Jr
Jul/Aug 2001 Pg. 246-253	Quality Assurance for Sterile Products Author(s): Kastango Eric S, Douglass Kate
Mar/Apr 2008 Pg. 156-160	Compatibility and Stability of Palonosetron Hydrochloride with Four Neuromuscular Blocking Agents During Simulated Y-Site Administration Author(s): Trusley Craig, Ben Michel, Kupiec Thomas C, Trissel Lawrence A
Nov/Dec 2022 Pg. 446-466	Compounding with Biotechnology Products, Part 2: Product-specific Considerations Author(s): Allen Loyd V Jr
Sep/Oct 2018 Pg. 417-423	Prolonged In-use Stability of Reconstituted Herceptin in Commercial Intravenous Bags Author(s): Nalenz Heiko, Köpf Ellen, Dietel Elke
Sep/Oct 2005 Pg. 396-298	Stability and Subjective Taste Acceptability of Four Glycopyrrolate Solutions for Oral Administration Author(s): Landry Christine, Forest Jean-Marc, Hildgen Patrice
Jan/Feb 2003 Pg. 44-45	Determining the Availability of a Commercial Drug Author(s):
Mar/Apr 2003 Pg. 114-116	Autoclaves for the Sterilization of Compounded Parenteral Products Author(s): Rahe Hank
May/Jun 2006 Pg. 221	Enalapril Maleate 1-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Nov/Dec 2018 Pg. 494	Enalapril Maleate 1 mg/mL in SyrSpend SF pH4 Oral Suspension Author(s): Allen Loyd V Jr
May/Jun 2021 Pg. 246-257	Prolonged In-use Stability of Diluted Atezolizumab in Commercial Intravenous Bags Author(s): Hui Ada, Yin Jian, Liu Wei, Zheng Kai
Jan/Feb 2022 Pg. 56	Enalapril Maleate 1 mg-mL in Ora-Plus and Ora-Sweet Suspension Author(s): Allen Loyd V Jr
Mar/Apr 2016 Pg. 167-174	Stability of Atenolol, Clonazepam, Dexamethasone, Diclofenac Sodium, Diltiazem, Enalapril Maleate, Ketoprofen, Lamotrigine, Penicillamine-D, and Thiamine in SyrSpend SF PH4 Oral Suspensions Author(s): Polonini HC, Loures S, Lima LC, Ferreira AO, Brandão MA
Jan/Feb 1997 Pg. 60-63	Stability of an Extemporaneously Formulated Levothyroxine Sodium Syrup Compounded from Commercial Tablets Author(s): Alexander Kenneth S, Kothapalli Madhu R, Dollimor David
May/Jun 2008 Pg. 216-229	Microbial Air-Sampling Equipment, Part 1: Meeting United States Pharmacopeia Chapter <797> Standards Author(s): Kastango Eric S